10.1371/journal.pone.0048993.g003
Yann Neuzillet
Yann
Neuzillet
Xavier Paoletti
Xavier
Paoletti
Slah Ouerhani
Slah
Ouerhani
Pierre Mongiat-Artus
Pierre
Mongiat-Artus
Hany Soliman
Hany
Soliman
Hugues de The
Hugues
de The
Mathilde Sibony
Mathilde
Sibony
Yves Denoux
Yves
Denoux
Vincent Molinie
Vincent
Molinie
Aurélie Herault
Aurélie
Herault
May-Linda Lepage
May-Linda
Lepage
Pascale Maille
Pascale
Maille
Audrey Renou
Audrey
Renou
Dimitri Vordos
Dimitri
Vordos
Claude-Clément Abbou
Claude-Clément
Abbou
Ashraf Bakkar
Ashraf
Bakkar
Bernard Asselain
Bernard
Asselain
Nadia Kourda
Nadia
Kourda
Amel El Gaaied
Amel
El Gaaied
Karen Leroy
Karen
Leroy
Agnès Laplanche
Agnès
Laplanche
Simone Benhamou
Simone
Benhamou
Thierry Lebret
Thierry
Lebret
Yves Allory
Yves
Allory
François Radvanyi
François
Radvanyi
Combined <i>FGFR3</i> and <i>TP53</i> mutation frequencies according to the stage/grade group.
Public Library of Science
2012
mutation
frequencies
2012-12-13 01:42:56
Figure
https://plos.figshare.com/articles/figure/_Combined_FGFR3_and_TP53_mutation_frequencies_according_to_the_stage_grade_group_/196176
<p>Proportion of tumours with both <i>FGFR3</i> and <i>TP53</i> mutations (orange), with <i>FGFR3</i> mutations and wild-type <i>TP53 wild-type</i> (grey), with wild-type <i>FGFR3</i> and mutated <i>TP53</i> (purple), or with wild-type <i>FGFR3</i> and wild-type <i>TP53</i> (blue), as a function of stage/grade. The number of cases in each subgroup is indicated in the corresponding rectangle.</p>